Targeting The Mutant: NTHI’s NEO100 Data Could Open a New Front in the Fight Against Brain Cancer

Go back to Targeting The Mutant: NTHI’s NEO100 Data Could Open a New Front in the Fight Against Brain Cancer
(NASDAQ: NTHI) Delayed: 5.03 +0.24 (5.01%)
Previous Close $4.79    52 Week High
Open $4.76    52 Week Low
Day High $5.20    P/E N/A 
Day Low $4.74    EPS
Volume 102,431